期刊文献+

高场强核磁共振在前列腺癌术前诊断及分期中的应用价值 被引量:4

Clinical value of 3T magnetic resonance imaging in the staging diagnosis and preoperative evaluation of prostate cancer
下载PDF
导出
摘要 目的探讨高场强核磁共振检查在前列腺癌诊断和术前分期中的作用。方法选择该院收治的68例术后病理证实为前列腺癌的患者为观察对象,所有患者均接受术前3.0T高场强核磁共振检查,分析患者的临床诊断和术前影像学分期,并与术后病理学分期结果进行比较。结果该组磁共振检查前列腺癌术前分期的诊断准确率达到77.9%(53/68),B期患者诊断特异度(92.2%)最高,D期患者诊断敏感度(90.5%)和准确度(92.3%)最高。MRI术前分期与术后病理分期结果有显著相关性(P<0.05)。结论 3.0 T高场强核磁共振应用于前列腺癌的术前诊断和分期判断,具有较高的临床应用价值。 【Objective】To explore the clinical value of 3T magnetic resonance imaging in the staging diagnosis and preoperative evaluation of prostatic carcinoma.【Methods】68 cases of pathologically confirmed prostatic carcinoma were enrolled as observation group, all patients underwent preoperative 3T magnetic resonance examination,and the clinical data and preoperative staging results were retrospectively analyzed. The MRI staging of the carcinoma before surgical resection was compared with the pathological staging of the malignancy after radical prostatectomy.【Results】The diagnostic accuracy of preoperative MRI staging in this group reached 77.9%(53/68), the diagnostic specificity was highest in staging B subgroup, and the diagnosis sensitivity and accuracy were highest in staging D subgroup. There were significantly correlation betweenpreoperative MRI staging and pathological staging(P 〈0.05).【Conclusion】3T magnetic resonance imaging applied to prostatic carcinoma preoperative diagnosis and staging hasa high clinical value.
作者 李珂
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第19期84-87,共4页 China Journal of Modern Medicine
关键词 高场强核磁共振 前列腺癌 敏感度 特异度 3T magnetic resonance imaging prostate cancer sensitivity specificity
  • 相关文献

参考文献2

二级参考文献15

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献176

同被引文献27

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部